BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38134587)

  • 1. Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature.
    Gonzalez T; Nie Q; Chaudhary LN; Basel D; Reddi HV
    Cancer Genet; 2024 Apr; 282-283():1-8. PubMed ID: 38134587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-based DNA methylation as biomarker for breast cancer: a systematic review.
    Tang Q; Cheng J; Cao X; Surowy H; Burwinkel B
    Clin Epigenetics; 2016; 8():115. PubMed ID: 27895805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen.
    Jeschke J; Van Neste L; Glöckner SC; Dhir M; Calmon MF; Deregowski V; Van Criekinge W; Vlassenbroeck I; Koch A; Chan TA; Cope L; Hooker CM; Schuebel KE; Gabrielson E; Winterpacht A; Baylin SB; Herman JG; Ahuja N
    Epigenetics; 2012 Jul; 7(7):701-9. PubMed ID: 22647880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Methylation Markers for Breast Cancer Detection in the Developing World.
    Downs BM; Mercado-Rodriguez C; Cimino-Mathews A; Chen C; Yuan JP; Van Den Berg E; Cope LM; Schmitt F; Tse GM; Ali SZ; Meir-Levi D; Sood R; Li J; Richardson AL; Mosunjac MB; Rizzo M; Tulac S; Kocmond KJ; de Guzman T; Lai EW; Rhees B; Bates M; Wolff AC; Gabrielson E; Harvey SC; Umbricht CB; Visvanathan K; Fackler MJ; Sukumar S
    Clin Cancer Res; 2019 Nov; 25(21):6357-6367. PubMed ID: 31300453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation and breast cancer: A way forward (Review).
    Vietri MT; D'Elia G; Benincasa G; Ferraro G; Caliendo G; Nicoletti GF; Napoli C
    Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34726251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review.
    Terp SK; Stoico MP; Dybkær K; Pedersen IS
    Clin Epigenetics; 2023 Feb; 15(1):24. PubMed ID: 36788585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-Blood DNA Methylation Markers in Early Detection of Breast Cancer: A Systematic Literature Review.
    Guan Z; Yu H; Cuk K; Zhang Y; Brenner H
    Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):496-505. PubMed ID: 30487132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
    Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
    Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
    Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
    Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrantly Methylated cfDNA in Body Fluids as a Promising Diagnostic Tool for Early Detection of Breast Cancer.
    Stastny I; Zubor P; Kajo K; Kubatka P; Golubnitschaja O; Dankova Z
    Clin Breast Cancer; 2020 Dec; 20(6):e711-e722. PubMed ID: 32792225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection.
    Markou Α; Londra D; Tserpeli V; Kollias Ι; Tsaroucha E; Vamvakaris I; Potaris K; Pateras I; Kotsakis Α; Georgoulias V; Lianidou Ε
    Clin Epigenetics; 2022 May; 14(1):61. PubMed ID: 35538556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer.
    Li SY; Wu HC; Mai HF; Zhen JX; Li GS; Chen SJ
    J Cell Biochem; 2019 Jan; 120(1):658-670. PubMed ID: 30203578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
    Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
    Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized Marker System for Early Diagnosis of Breast Cancer.
    Burdennyy AM; Filippova EA; Khodyrev DS; Pronina IV; Lukina SS; Ivanova NA; Kazubskaya TP; Loginov VI; Braga EA
    Bull Exp Biol Med; 2021 Nov; 172(1):57-62. PubMed ID: 34791555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter methylation and the detection of breast cancer.
    Brooks J; Cairns P; Zeleniuch-Jacquotte A
    Cancer Causes Control; 2009 Nov; 20(9):1539-50. PubMed ID: 19768562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrantly methylated DNA as a biomarker in breast cancer.
    Kristiansen S; Jørgensen LM; Guldberg P; Sölétormos G
    Int J Biol Markers; 2013; 28(2):141-50. PubMed ID: 23564623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenome-wide DNA methylation and risk of breast cancer: a systematic review.
    Ennour-Idrissi K; Dragic D; Durocher F; Diorio C
    BMC Cancer; 2020 Oct; 20(1):1048. PubMed ID: 33129307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening.
    Kloten V; Becker B; Winner K; Schrauder MG; Fasching PA; Anzeneder T; Veeck J; Hartmann A; Knüchel R; Dahl E
    Breast Cancer Res; 2013 Jan; 15(1):R4. PubMed ID: 23320751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation-based biomarkers in serum of patients with breast cancer.
    Van De Voorde L; Speeckaert R; Van Gestel D; Bracke M; De Neve W; Delanghe J; Speeckaert M
    Mutat Res; 2012; 751(2):304-325. PubMed ID: 22698615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide cell-free DNA methylation analyses improve accuracy of non-invasive diagnostic imaging for early-stage breast cancer.
    Liu J; Zhao H; Huang Y; Xu S; Zhou Y; Zhang W; Li J; Ming Y; Wang X; Zhao S; Li K; Dong X; Ma Y; Qian T; Chen X; Xing Z; Zhang Y; Chen H; Liu Z; Pang D; Zhou M; Wu Z; Wang X; Wang X; Wu N; Su J
    Mol Cancer; 2021 Feb; 20(1):36. PubMed ID: 33608029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.